SBC Medical [SBC] vs Equifax [EFX] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: SBC Medical Group Holdings Inc. wins in 13 metrics, Equifax Inc. wins in 6 metrics, with 0 ties. SBC Medical Group Holdings Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric SBC Medical Group Holdings Inc. Equifax Inc. Better
P/E Ratio (TTM) 6.80 31.45 SBC Medical Group Holdings Inc.
Price-to-Book Ratio 1.41 4.69 SBC Medical Group Holdings Inc.
Debt-to-Equity Ratio 19.61 113.35 SBC Medical Group Holdings Inc.
PEG Ratio 6.80 0.93 Equifax Inc.
EV/EBITDA 3.58 13.78 SBC Medical Group Holdings Inc.
Profit Margin (TTM) 29.37% 11.12% SBC Medical Group Holdings Inc.
Operating Margin (TTM) 32.47% 17.45% SBC Medical Group Holdings Inc.
EBITDA Margin (TTM) 32.47% 17.45% SBC Medical Group Holdings Inc.
Return on Equity 22.28% 14.37% SBC Medical Group Holdings Inc.
Return on Assets (TTM) 13.05% 6.27% SBC Medical Group Holdings Inc.
Free Cash Flow (TTM) $21.96M $1.13B Equifax Inc.
Dividend Yield N/A 1.08% N/A
1-Year Return -37.43% -37.25% Equifax Inc.
Price-to-Sales Ratio (TTM) 2.01 3.43 SBC Medical Group Holdings Inc.
Enterprise Value $251.33M $26.58B Equifax Inc.
EV/Revenue Ratio 1.45 4.23 SBC Medical Group Holdings Inc.
Gross Profit Margin (TTM) 73.11% 53.48% SBC Medical Group Holdings Inc.
Revenue per Share (TTM) $2 $51 Equifax Inc.
Earnings per Share (Diluted) $0.50 $5.68 Equifax Inc.
Beta (Stock Volatility) 0.99 N/A N/A
Short % of Float 2.34% 4.62% SBC Medical Group Holdings Inc.

SBC Medical Group Holdings Inc. vs Equifax Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SBC Medical Group Holdings Inc.-4.06%2.56%-2.44%-17.95%-9.60%-26.10%
Equifax Inc.-3.38%8.17%2.25%-15.34%-15.60%-17.72%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SBC Medical Group Holdings Inc.-37.43%-70.92%-70.92%-83.37%-99.98%-99.99%
Equifax Inc.-37.25%-22.40%-28.97%32.42%357.60%359.25%

Performance & Financial Health Analysis: SBC Medical Group Holdings Inc. vs Equifax Inc.

MetricSBCEFX
Market Information
Market Cap i$343.63M$21.10B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i195,4991,824,577
90 Day Avg. Volume i94,5431,744,279
Last Close$3.07$170.16
52 Week Range$2.78 - $5.75$156.47 - $275.91
% from 52W High-46.61%-38.33%
All-Time High$49,900.00 (Jun 21, 2010)$309.63 (Sep 16, 2024)
% from All-Time High-99.99%-45.04%
Growth Metrics
Quarterly Revenue Growth-0.11%0.14%
Quarterly Earnings Growth1.17%0.29%
Financial Health
Profit Margin (TTM) i0.29%0.11%
Operating Margin (TTM) i0.32%0.17%
Return on Equity (TTM) i0.22%0.14%
Debt to Equity (MRQ) i19.61113.35
Cash & Liquidity
Book Value per Share (MRQ)$2.42$38.06
Cash per Share (MRQ)$1.60$1.54
Operating Cash Flow (TTM) i$24.67M$1.63B
Levered Free Cash Flow (TTM) i$25.41M$1.01B
Dividends
Last 12-Month Dividend Yield iN/A1.08%
Last 12-Month Dividend iN/A$2.06

Valuation & Enterprise Metrics Analysis: SBC Medical Group Holdings Inc. vs Equifax Inc.

MetricSBC (Apr 26, 2026)EFX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i6.8031.45
Forward P/E i6.8017.39
PEG Ratio i6.800.93
Price to Sales (TTM) i2.013.43
Price to Book (MRQ) i1.414.69
Market Capitalization
Market Capitalization i$343.63M$21.10B
Enterprise Value i$251.33M$26.58B
Enterprise Value Metrics
Enterprise to Revenue i1.454.23
Enterprise to EBITDA i3.5813.78
Risk & Other Metrics
Beta i0.99N/A
Book Value per Share (MRQ) i$2.42$38.06

Financial Statements Comparison: SBC Medical Group Holdings Inc. vs Equifax Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSBC (2025)EFX (2025)
Revenue/Sales i173.61M6.07B
Cost of Goods Sold i46.32M2.65B
COGS % of Revenue i26.7%43.6%
Gross Profit i127.28M3.43B
Gross Margin i73.3%56.4%
Research & Development iN/AN/A
Operating Income (EBIT) i67.49M1.10B
Operating Margin i38.9%18.0%
EBITDA i74.16M1.83B
EBITDA Margin i42.7%30.2%
Pre-Tax Income i82.07M894.90M
Pre-Tax Income % of Revenue i47.3%14.7%
Income Tax i31.02M230.60M
Income Tax % of Revenue i17.9%3.8%
Net Income (Profit) i51.05M664.30M
Profit Margin i29.4%10.9%

Balance Sheet & Liquidity Metrics

MetricSBC (2025)EFX (2025)
Cash & Equivalents i163.77M180.80M
Total Current Assets i231.22M1.41B
Total Current Assets % of Revenue i133.2%23.2%
Total Current Liabilities i61.12M2.34B
Total Current Liabilities % of Revenue i35.2%38.4%
Long-Term Debt i37.99M4.06B
Long-Term Debt % of Revenue i21.9%66.8%
Total Shareholders Equity i263.30M4.74B
Retained Earnings i240.45M6.45B
Retained Earnings % of Revenue i138.5%106.1%
Property, Plant & Equipment i8.82M299.60M

Cash Flow Statement Comparison

MetricSBC (2025)EFX (2025)
Operating Cash Flow i50.77M1.62B
Operating Cash Flow % of Revenue i29.2%26.6%
Capital Expenditures i4.77MN/A
Free Cash Flow i21.96M1.13B
FCF Margin i12.7%18.7%
Debt Repayment i-1.68M-400.20M
Common Stock Repurchase i-5.00M-927.50M

Short Interest & Institutional Ownership Analysis

MetricSBCEFX
Shares Short i231,1494.76M
Short Ratio i6.423.04
Short % of Float i2.34%4.62%
Shares Outstanding i102.58M119.30M
Float Shares i91.42M118.80M
% Held by Insiders i82.20%0.64%
% Held by Institutions i1.31%100.16%
% Held by Public i16.49%-0.80%

Dividend Analysis & Yield Comparison: SBC Medical Group Holdings Inc. vs Equifax Inc.

MetricSBCEFX
Last 12-Month Dividend iN/A$2.06
Last 12-Month Dividend Yield iN/A1.08%
3-Year Avg Annual Dividend iN/A$1.73
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$5.18
Ex-Dividend DateN/AMar 09, 2026